S-propargyl-cysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: The contribution of the hydrogen sulfide-mediated pathway
(2009)
Journal Article
Wang, Q., Liu, H. R., Mu, Q., Rose, P., & Zhu, Y. Z. (2009). S-propargyl-cysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: The contribution of the hydrogen sulfide-mediated pathway. Journal of Cardiovascular Pharmacology, 54(2), 139-146. https://doi.org/10.1097/FJC.0b013e3181ac8e12
In this study, we determined the cardioprotective effects of S-propargyl-cysteine (SPRC), a structural analog of S-allylcysteine (SAC), using in vivo models of acute myocardial infarction (MI) and in vitro hypoxic cardiomyocytes models. MI was create... Read More about S-propargyl-cysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: The contribution of the hydrogen sulfide-mediated pathway.